In a glioma study, using the tdTomato mice, it was indicated that the IFN-I signal triggered by STING blocked Treg cells and promoted CD8+ T-cell response; furthermore, the efficacy of OVA-targeted peptide vaccine was enhanced by STING agonist (Ohkuri et al., 2014). The gene discussed is STING1; the disease is central nervous system cancer.